36.45 USD
↘ 0.13 (0.34%)PRE MARKET (AS OF 04:57 AM EDT)
Xenon Pharmaceuticals Inc
XENENASDAQ • USD
Market: OPEN
Xenon Pharmaceuticals Inc (XENE) is currently trading at $36.45. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest XENE is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 6, 2026.
Open?$36.32
High?$36.45
Low?$36.32
Prev. Close?$36.57
Volume?1.1K
Avg. Volume?2.1M
VWAP?$36.44
Rel. Volume?0.00x
Bid / Ask
Bid?$31.39 × 100
Ask?$41.77 × 100
Spread?$10.38
Midpoint?$36.58
Valuation & Ratios
Market Cap?3.5B
Shares Out?96.7M
Float?90.8M
Float %?93.9%
P/E Ratio?N/A
P/B Ratio?2.85
EPS?-$4.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
3.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
BURNABY,
Phone: (604) 484-3300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?37.94Safe
Confidence?52%Low
Short InterestVery High
Short % of Float?7.10%Elevated
Short Interest?6.4M
Days to Cover?12.2
Free Float90.8M
Avg Daily Volume527.3K
Settlement Date2026-09-15
Financial Health
Current Ratio?21.02Strong
Quick Ratio?21.02Strong
Cash Ratio?2.66Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.85CHEAP▾
Peers100
S&P58
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-32.9%WEAK▾
S&P6
ROA?-31.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-338527000
Enterprise Value?$3.4B
Fundamentals ratios updated end of day